Core Insights - The 34th European Academy of Dermatology and Venereology (EADV 2025) concluded successfully in Paris, where the Chinese beauty brand, Shangmei Co., made a significant debut by releasing the "2025 KANSU Peptide Research and Efficacy Skincare Application Yearbook" [1] - This publication, which encapsulates 22 years of research on peptides by KANSU, was also showcased at the 2025 China Fragrance and Cosmetic Industry Annual Conference and Expo (CAME), highlighting China's innovative contributions to anti-aging solutions [1] Group 1 - The "KANSU Peptide Yearbook" is edited by renowned dermatology experts, showcasing the brand's deep commitment to peptide research and establishing its credibility in the field [3] - The yearbook serves as a practical guide for consumers and a testament to the brand's long-term commitment to scientific development in the industry [6] - It outlines a comprehensive framework that combines global perspectives with local insights, detailing over 50 years of peptide technology evolution [6] Group 2 - The yearbook presents significant market transformation results, with the "Red Waist 2.0" series showing a 38.57% reduction in cheek wrinkle length and a 33.83% increase in skin hydration [7] - The KANSU X Peptide Super Frequency Cream demonstrated a 27.59% increase in collagen and a 30.57% improvement in elastin after 28 days of testing, setting new industry benchmarks [7] - These quantifiable results address the industry's challenge of measuring anti-aging effects, providing consumers with clear efficacy references [7] Group 3 - The yearbook emphasizes the importance of long-term research investment in building core competitiveness in the anti-aging sector, reflecting on the industry's short-termism [10] - It documents KANSU's journey from initiating peptide research in 2003 to achieving significant milestones in innovation and application [11] - The yearbook's authority stems from KANSU's unique research accumulation and international recognition, showcasing a robust peptide research system [11] Group 4 - Karl Lintner, a pioneer in peptide technology, praised KANSU's application of cyclic peptides, affirming its contributions to foundational research and product development [13] - The dual launch at EADV and CAME signifies KANSU's strategic positioning to engage globally while remaining rooted in China [13] - The yearbook sets future goals for KANSU to leverage AI and computational biology in advancing peptide research, marking a transition from "Made in China" to "Intelligent Manufacturing in China" [13]